Since it was effective for restoring glucagon release in animals, it has been postulated that ZT-01 may be able to restore the absent or diminished glucagon responses to hypoglycemia in individuals with T1D (5), although this effect has yet to be fully studied in humans. This evidence concerns the gene GCG and Hypoglycemia.